Thomas King

Thomas Braxton King is Executive Chairman at Concentric Analgesics, Inc. since 2018 and Director at Faraday Pharmaceuticals, Inc. since 2014.
Former roles include President, Chief Executive Officer & Director at Anesta Corp.
from 1997 to 2000; President, Chief Executive Officer, CFO & CAO at Alexza Pharmaceuticals, Inc. in 2016; President, Chief Executive Officer & Director at Cognetix, Inc. from 2002 to 2003; Chairman at Achieve Life Sciences, Inc. from 2024 to 2026; Chairman at Kinaset Therapeutics, Inc. from 2020 to 2026; Director at Orphan Medical, Inc. in 2007; Independent Director at VIVUS, Inc. from 2018 to 2020; Director at Achaogen, Inc.; Director at Faraday Pharmaceuticals, Inc. (Washington); Director at Symphony Allegro, Inc.; Independent Director at Satsuma Pharmaceuticals, Inc. from 2017 to 2023; Independent Director at TFF Pharmaceuticals, Inc. from 2023 to 2024.
Education includes an undergraduate degree from McPherson College in 1977 and an MBA from Kansas University School of Business.